Gene Expression Profiling of Structural and Functional High-Risk Multiple Myeloma

被引：0
|
作者：
Binder, Moritz [1 ]
Rajkumar, S. Vincent [1 ]
Lacy, Martha Q. [1 ]
Haug, Jessica L. [1 ]
Dispenzieri, Angela [1 ]
Henderson, Kimberly J. [1 ]
Kimlinger, Teresa K. [1 ]
Stewart, A. Keith [2 ]
Bergsagel, P. Leif [2 ]
Kumar, Shaji K. [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Scottsdale, AZ USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-124637
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3061
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Global Gene Expression Profiling in the Study of Multiple Myeloma
    John D. Shaughnessy
    International Journal of Hematology, 2003, 77 : 213 - 225
  • [22] A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
    Shaughnessy, John D.
    Zhan, Fenghuang
    Burington, Bart E.
    Huang, Yongsheng
    Colla, Simona
    Hanamura, Ichiro
    Stewart, James P.
    Kordsmeier, Bob
    Randolph, Christopher
    Williams, David R.
    Xiao, Yan
    Xu, Hongwei
    Epstein, Joshua
    Anaissie, Elias
    Krishna, Somashekar G.
    Cottler-Fox, Michele
    Hollmig, Klaus
    Mohiuddin, Abid
    Pineda-Roman, Mauricio
    Tricot, Guido
    van Rhee, Frits
    Sawyer, Jeffrey
    Alsayed, Yazan
    Walker, Ronald
    Zangari, Maurizio
    Crowley, John
    Barlogie, Bart
    BLOOD, 2007, 109 (06) : 2276 - 2284
  • [23] Osteoclast Gene Expression Profiling in Multiple Myeloma.
    Moreaux, Jerome
    Hose, Dirk
    Reme, Thierry
    Moine, Philippe
    Mahtouk, Karene
    Moos, Marion
    Requirand, Guilhem
    De Vos, John
    Rossi, Jean Francois
    Goldschmidt, Hartmut
    Klein, Bernard
    BLOOD, 2008, 112 (11) : 945 - 945
  • [24] Gene expression profiling as a prognostic tool in multiple myeloma
    Black, Harmony
    Glavey, Siobhan
    CANCER DRUG RESISTANCE, 2021, 4 (04) : 1008 - 1018
  • [25] Global gene expression profiling in the study of multiple myeloma
    Shaughnessy, JD
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 77 (03) : 213 - 225
  • [26] Evaluation of Functional and Cytogenetic High-Risk Multiple Myeloma Using RealWorld Data
    Kansagra, Ankit
    Hansen, Eric
    Belli, Andrew J.
    Goran, Stefanie
    Wang, Ching-Kun
    BLOOD, 2021, 138
  • [27] Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma
    Jethava, Y.
    Mitchell, A.
    Zangari, M.
    Waheed, S.
    Schinke, C.
    Thanendrarajan, S.
    Sawyer, J.
    Alapat, D.
    Tian, E.
    Stein, C.
    Khan, R.
    Heuck, Cj
    Petty, N.
    Avery, D.
    Steward, D.
    Smith, R.
    Bailey, C.
    Epstein, J.
    Yaccoby, S.
    Hoering, A.
    Crowley, J.
    Morgan, G.
    Barlogie, B.
    van Rhee, F.
    BLOOD CANCER JOURNAL, 2016, 6 : e453 - e453
  • [28] Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma
    Y Jethava
    A Mitchell
    M Zangari
    S Waheed
    C Schinke
    S Thanendrarajan
    J Sawyer
    D Alapat
    E Tian
    C Stein
    R Khan
    C J Heuck
    N Petty
    D Avery
    D Steward
    R Smith
    C Bailey
    J Epstein
    S Yaccoby
    A Hoering
    J Crowley
    G Morgan
    B Barlogie
    F van Rhee
    Blood Cancer Journal, 2016, 6 : e453 - e453
  • [29] A rational approach to functional high-risk myeloma
    Gay, Francesca
    Bertuglia, Giuseppe
    Mina, Roberto
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2023, (01) : 433 - 442
  • [30] High-risk multiple myeloma: Redefining genetic, clinical, and functional high-risk disease in the era of molecular medicine and immunotherapy
    Rees, Matthew J.
    Kumar, Shaji
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (08) : 1560 - 1575
12345